Version 1.102 release notes
Release notes
Changes to the NVC have been made since the last release v1.101 (2026-02-26). For your reference, please find a summary of the changes below:
Vaccine lots
- Refer to the 'Vaccine Lots' tab in the Excel workbook to view which specific vaccine lots are new. Column C contains a flag indicating whether a lot is new (marked as 'YES' or 'NO'). You can also find these flags in column N of the 'LotTradenameMapping' tab
Tradename
- 35661000087108 | [Inf] Supemtek | (Updated MAH)
- 34631000087100 | [Anth] BioThrax | (Updated MAH)
- 380541000087106 | [MMR] M-M-RVAXPRO| (Updated French abbreviation)
Antigen/Immunoglobulin/Antitoxin
- 871834006 | Neisseria meningitidis serogroup A capsular polysaccharide antigen conjugated | (New, replaced 52821000087108)
- 52821000087108 | [Men-C-A] Meningococcal conjugate A vaccine | (Inactivated)
- 767467006 | Respiratory syncytial virus immune globulin | (Updated French Display Name)
Disease
- 240532009 | Human papilloma virus infection | (Updated French Display name)
- 359814004 Mpox | (Updated French Display name)
- 111864006 | Chikungunya fever | (Updated French Display name)
Market authorization holder
- 214 new market authorization concept codes were added to the NVC after they were introduced in the Canadian SNOMED CT Reference Sets by Canada Health Infoway.
Summary of changes
- Antigen / Immunoglobulin / Antitoxin: 3
- Vaccine-Preventable Disease: 3
- Market authorization holder: 214
- Tradename immunizing agent: 3
- Vaccine lot: 8
- Version:
- 1.6.0